A global pharmacopoeia - overcoming hurdles to harmonisation Jo Barnes Newsletter Article 04 February 2013 Pages: 3 - 4
Existing anti-parkinsonian therapies still hold promise Newsletter Article 04 February 2013 Pages: 4 - 4
More flexible trial protocols needed for new anti-HIV drugs Newsletter Article 04 February 2013 Pages: 5 - 5
Maximum androgen blockade: does it improve survival in prostate cancer? Newsletter Article 04 February 2013 Pages: 6 - 6
US study favours omeprazole over ranitidine for oesophagitis Newsletter Article 04 February 2013 Pages: 7 - 7
Fetal nigral transplantation benefits Parkinson’s patients Newsletter Article 04 February 2013 Pages: 10 - 10
PIXY-321 combines the biological effects of GM-CSF and IL-3 Newsletter Article 04 February 2013 Pages: 10 - 10
Rolipram - a potent and specific inhibitor of HIV replication Newsletter Article 04 February 2013 Pages: 12 - 12
Corticosteroids ineffective for acute rejection in lung transplant recipients Newsletter Article 04 February 2013 Pages: 12 - 12
Choosing between anticonvulsant drugs Gill Higgins Newsletter Article 04 February 2013 Pages: 13 - 14
Broader antibacterial spectrum improves outcome after PROM Newsletter Article 04 February 2013 Pages: 15 - 15
Intensive therapy does not affect progression to albuminuria in IDDM Newsletter Article 04 February 2013 Pages: 15 - 15
ACE inhibitors a potential option for migraine prophylaxis? Newsletter Article 04 February 2013 Pages: 16 - 16
Panic disorder: ‘highly encouraging’ results with low-dose venlafaxine Newsletter Article 04 February 2013 Pages: 16 - 16
Trihexyphenidyl + inosine pranobex effective in SSPE Newsletter Article 04 February 2013 Pages: 16 - 16
MAC therapy - first evidence of survival effect Janet Kenyon Newsletter Article 04 February 2013 Pages: 17 - 18
No interaction between IV heparin and nitrates in cardiovascular disorders Newsletter Article 04 February 2013 Pages: 20 - 20
No increased risk of ovarian or breast cancer with IVF drugs Newsletter Article 04 February 2013 Pages: 21 - 21